1 / 7

Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109

Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109. Characteristics of study population at index date. Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109. Type of statin used. Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109.

lkrueger
Download Presentation

Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109

  2. Characteristics of study population at index date Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109

  3. Type of statin used Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109

  4. Outcomes where short-term effects may be apparent-all time periods after the index date and first 12 months shown separately Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109

  5. Outcomes with more longer term onset: first 12 months after index date excluded Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109

  6. All cancers stratified by duration of follow-up Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109

  7. Major vascular outcomes and all cause mortality Smeeth L, et al. Br J Clin Pharmacol 2009;67:99-109

More Related